LJPC
La Jolla Pharmaceutical Company
LJPC
LJPC
Delisted
LJPC was delisted on the 19th of August, 2022.
80 hedge funds and large institutions have $163M invested in La Jolla Pharmaceutical Company in 2019 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 22 increasing their positions, 18 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
25% less call options, than puts
Call options by funds: $340K | Put options by funds: $455K
43% less capital invested
Capital invested by funds: $286M → $163M (-$122M)
Holders
80
Holding in Top 10
3
Calls
$340K
Puts
$455K
Top Buyers
| 1 | +$6.82M | |
| 2 | +$6.45M | |
| 3 | +$3.79M | |
| 4 |
Millennium Management
New York
|
+$3.62M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.69M |
Top Sellers
| 1 | -$41M | |
| 2 | -$30.8M | |
| 3 | -$12.3M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$9.96M |
| 5 |
EU
Emory University
Atlanta,
Georgia
|
-$1.41M |